Physician profile
David C Arend
NPI 1548478118
$947.87
in general payments reported to CMS, 2019-2025
18 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2021: $151 · 2022: $153 · 2023: $92.33 · 2024: $160 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $197.86 | 2019-2023 | Lumenis Pulse 120h |
| Janssen Biotech, INC. | $152.05 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| 180 Medical, INC. | $129.07 | 2019-2023 | Cure Catheter, Gentlecath |
| Procept Biorobotics Corporation | $124.83 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $60.22 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $44.07 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $42.37 | 2025 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Allergan, INC. | $29.35 | 2019 | |
| Edap Technomed INC | $25.04 | 2025 | |
| Kci USA, INC. | $19.64 | 2022 | |
| Medtronic, INC. | $18.92 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.63 | 2025 | |
| Endo Pharmaceuticals INC. | $17.74 | 2023 | Xiaflex, Aveed |
| Rochester Medical Corporation | $15.23 | 2019 | |
| Astellas Pharma US INC | $15.05 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.06 | 2023 | Botox |
| Urogen Pharma, INC. | $12.01 | 2021 | |
| Progenics Pharmaceuticals, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Arend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.